Mr.Santosh Meena, Senior Research Analyst, Swastika Investmart, shares his opinion on the stock market in various publications. Refer to the below links for more details:
Publication: The Economic Times
Headline: Buy, sell or hold: What should you do with Supriya Lifescience after solid debut?
https://economictimes.indiatimes.com/markets/stocks/news/buy-sell-or-hold-what-should-you-do-with-supriya-lifescience-after-solid-debut/articleshow/88538993.cms?from=mdr
Publication: Mint
Headline: Supriya Lifescience shares make strong debut. Should you hold, buy or sell?
https://www.livemint.com/market/stock-market-news/supriya-lifescience-shares-make-strong-debut-should-you-hold-buy-or-sell-11640668263314.html
Publication: Outlook
Headline: Supriya Lifescience Shares List At Over 55% Premium. Should You Invest?
https://www.outlookindia.com/website/story/business-news-supriya-lifescience-shares-list-at-over-55-premium-should-you-invest/407121
Publication: Business Standard
Headline: Supriya Lifescience lists 55% higher over issue price; buy, sell or hold?
https://www.business-standard.com/article/markets/supriya-lifescience-lists-55-higher-over-issue-price-buy-sell-or-hold-121122800256_1.html
Publication: Business Standard
Headline: MapmyIndia scales a record high, up 10%; stock surges 22% in last 2 days
https://www.business-standard.com/article/markets/mapmyindia-scales-a-record-high-up-10-stock-surges-22-in-last-2-days-121122900288_1.html
Publication: Hindustan
Headline: सुप्रिया लाइफसाइंस की शेयर बाजार में शानदार लिस्टिंग, स्टॉक 53% से अधिक प्रीमियम पर हुआ सूचीबद्ध
https://www.livehindustan.com/business/story-superb-listing-of-supriya-lifescience-in-the-stock-market-the-stock-was-listed-at-a-premium-of-more-than-53-percent-5433414.html
Publication: ET Now
Headline: Supriya Lifescience makes strong debut on D-Street, lists at over 55% premium - Should you invest?
https://www.timesnownews.com/business-economy/markets/article/supriya-lifescience-makes-strong-debut-on-d-street-lists-at-over-55-premium-should-you-invest/844383
Publication: Zee Business
Headline: Supriya Lifescience shares correct 6% post strong listing; what should investors do with this counter now?
https://www.zeebiz.com/market-news/news-supriya-lifescience-shares-correct-post-strong-listing-what-should-investors-do-with-this-counter-now-174641
Publication: Money Control
Headline: 'Double-digit return from D-Link India, NIIT, KNR Constructions possible in short term'
https://www.moneycontrol.com/news/business/markets/hot-stocks-double-digit-return-from-d-link-india-niit-knr-constructions-possible-in-short-term-7876721.html
Publication: Money Control
Headline: Supriya Lifescience lists with 55% premium, should investors hold or book profit?
https://www.moneycontrol.com/news/business/ipo/supriya-lifescience-lists-with-55-premium-should-investors-hold-or-book-profit-7873761.html
Publication: MSN
Headline: Supriya Lifescience lists with 55% premium, should investors hold or book profit?
https://www.msn.com/en-in/money/topstories/supriya-lifescience-lists-with-55-premium-should-investors-hold-or-book-profit/ar-AASc8Cn?li=AAgfW3S
Publication: Report Wire
Headline: Supriya Lifescience makes a powerful debut, lists at 55% premium over problem worth
https://www.reportwire.in/supriya-lifescience-makes-a-strong-debut-lists-at-55-premium-over-issue-price/
Publication: Henry Club
Headline: Supriya Lifesciences makes a strong start, listing at a premium of 55% over the issue price
https://henryclubs.com/supriya-lifesciences-makes-a-strong-start-listing-at-a-premium-of-55-over-the-issue-price/
